- Professor Maarten IJzerman
Victorian Comprehensive Cancer Centre; Chair of Cancer Health Services Research, School of Population and Global Health, University of Melbourne
Will Australia be left behind in the cancer genomics revolution?
Australian patients may not see the benefits of new genetic testing for diagnosis and treatment without new funding models says a University of Melbourne expert
Testing, testing, testing: Can blood tests help detect cancers early?
The COVID-19 pandemic showed our capacity to test at large scale, can we use these strategies for early detection of cancer ask University of Melbourne experts?
Is a delayed cancer diagnosis a consequence of COVID-19?
Some countries reported a 40 per cent decline in cancers during COVID-19, but people may not be visiting GPs with symptoms say University of Melbourne experts.
Better cancer treatments from better data analysis
New data-driven approaches can enhance cancer treatment for individuals and help allocate healthcare resources for everyone say University of Melbourne experts.
Improving Australia’s health system beyond the election
Australia has one of the world's best healthcare systems, but University of Melbourne experts say election promises are failing to address its sustainability.
Who is paying the price of whole-genome sequencing in cancer care?
University of Melbourne research finds that whole-genome sequencing is changing cancer treatment; but its real-world use needs to be measured and understood.